Molecular analysis identified ABC and GCB subtypes, with the ABC subtype benefiting more from the new regimen. The ...
Grewal, MD, assistant professor at the Winship Cancer Institute at Emory University discusses the significant and concerning ...
AI transforms cancer treatment by personalizing care and enhancing patient-provider communication, revolutionizing how patients manage their health.
A groundbreaking study reveals promising efficacy and safety of 212Pb-DOTAMTATE for treating neuroendocrine tumors, paving the way for future trials.
Daraxonrasib received FDA orphan drug designation for pancreatic cancer, targeting RAS mutations in pancreatic ductal ...
Combinations of androgen deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPIs) are the accepted ...
A new analysis reveals unique symptom burdens and quality of life challenges in younger patients with neuroendocrine tumors, ...
A recent trial evaluates the impact of dostarlimab on ovarian cancer treatment, revealing modest benefits and no significant safety concerns with niraparib.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback